Ocumension Therapeutics
Ocumension Therapeutics is a China‑based ophthalmic pharmaceutical platform, developing a diversified pipeline for uveitis, conjunctivitis, diabetic macular edema, glaucoma, and AMD, with strong growth potential in the expanding Chinese eye care market.
Headquarters: China (CHN)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- Employees: 505
- HQ: Suzhou
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.